Size of the transrectal ultrasound probe makes no difference in pain perception during TRUS-Bx under adequate local anesthesia

Koprulu S., Cevik I., Unlu N., DİLLİOĞLUGİL Ö.

INTERNATIONAL UROLOGY AND NEPHROLOGY, vol.44, no.1, pp.29-33, 2012 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 44 Issue: 1
  • Publication Date: 2012
  • Doi Number: 10.1007/s11255-011-9993-y
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.29-33
  • Keywords: Transrectal biopsy, Pain, Prostate, Transrectal ultrasonography, Lidocain, Size, PERIPROSTATIC LIDOCAINE INJECTION, GUIDED PROSTATE BIOPSY, DOUBLE-BLIND, INTRARECTAL LIDOCAINE, TRAMADOL
  • Kocaeli University Affiliated: Yes


In the great majority of the cases, transrectal ultrasound guided prostate biopsy (TRUS-Bx) is the definitive step in the diagnosis of prostate cancer (CaP). Although this procedure is well tolerated by most patients, it can result in considerable discomfort that can effectively be overcome with local injection anesthesia. In this study, we evaluated the effect of the size (i.e., circumference) of the transrectal probe on pain during TRUS-Bx.